Once the integration is complete by Q2 2026, the more than 125,000 providers and nearly 30 health systems that use Fullscript will be able to view patient sleep, readiness and activity trend data from those patients who opt in. They biometric smart-ring insights may be used to help inform clinician decision-making and support patient care. Fullscript—which will make the Oura Ring available through its catalogue—plans to expand to additional wearable devices, though it did not share further details.
“This [Oura] partnership is a monumental step toward real-time, whole-person care,” said Kyle Braatz, CEO and co-founder of Fullscript in a statement “Providers can now bring more context to treatment conversations and ongoing care management.”
Providers on Fullscript will be able to use Oura data to:
- Adjust protocols based on real‑time readiness and recovery signals
- Tailor sleep, stress and training recommendations with greater precision
- Track patient progress longitudinally
- Close the loop between measurement, diagnosis and treatment
The company added that clinicians will have a deeper understanding of how their patients are adjusting so they can spend less time gathering data from disparate places and more time delivering proactive, preventive care that benefits individuals, providers and health systems.
Supplement integration
Jeffrey Gladd, MD, chief medical officer at Fullscript, said he had patients throughout his career bring in their phones, open an app and hand him the device expecting him to scroll through six to nine months-worth of data to come up with insights.
“For me as a practitioner, and then ultimately our broader practitioner market, it’s having this [Oura data] now woven into the Fullscript platform so that when I’m sitting with the patient, I have the current supplements they’re taking because patients have done barcode-scanning with the Fullscript app of all the supplements they have,” he said.
Practitioners now have access to an consolidated list of all ingredients, patient lab results and Oura data, capturing the most important medical developments since the patient’s previous appointment.
Another outcome of the integration is that it may encourage medical practitioners like MDs, DOs and nurse practitioners—Fullscript’s fastest growing clinical base—to be further informed about supplements.
“So many of these conventional and traditional practitioners like me received very little nutrition and supplement education in their training,” Dr. Gladd said. “And so not only do we bring them a platform to deliver this care with the evidence-based protocols but we are also driving the education.”
Those protocols are tied to 300 evidence-based resources from Fullscript that allow practitioners to share supplement knowledge with their patients, including evidence of efficacy for certain ingredients. Fullscript partners with approximately 350 supplement brands.
“Again, this [wearable] data becomes really valuable,” Dr. Gladd said. “Here’s the signal we’re seeing in the data. Here’s a clinician’s treatment plan recommendation, including lifestyle plus supplementation. Now you’re able to actually see that work by tracking that in the Fullscript platform for the practitioner, but the patient is also seeing this as well in real time.”
